Vor Biopharma (NYSE:VOR) Price Target Cut to $17.50 by Analysts at HC Wainwright

Vor Biopharma (NYSE:VOR – Get Rating) had its price objective reduced by HC Wainwright from $20.00 to $17.50 in a research note published on Friday, The Fly reports. They currently have a buy rating on the stock. Separately, JMP Securities reissued a market outperform rating and set a $12.00 target price on shares of Vor […]

Related Keywords

United States , ,Delphia United States Inc ,Bourgeon Capital Management ,Tower Research Capital ,Ensign Peak Advisors Inc ,Vor Biopharma Inc ,Corton Capital Inc ,Vor Biopharma ,Get Rating ,Moderate Buy ,Peak Advisors Inc ,Research Capital ,Capital Management ,Vor Biopharma Daily ,Nyse Vor ,Kvor ,Medical ,Lower Price Target ,Hc Wainwright ,